BR9608284A - Composição farmacêutica compreendendo lactobacillus plantarum e arginina - Google Patents

Composição farmacêutica compreendendo lactobacillus plantarum e arginina

Info

Publication number
BR9608284A
BR9608284A BR9608284A BR9608284A BR9608284A BR 9608284 A BR9608284 A BR 9608284A BR 9608284 A BR9608284 A BR 9608284A BR 9608284 A BR9608284 A BR 9608284A BR 9608284 A BR9608284 A BR 9608284A
Authority
BR
Brazil
Prior art keywords
arginine
pharmaceutical composition
lactobacillus plantarum
composition
curative
Prior art date
Application number
BR9608284A
Other languages
English (en)
Inventor
Diya Adawi
Bengt Jeppson
Goran Molin
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of BR9608284A publication Critical patent/BR9608284A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9608284A 1995-05-09 1996-05-08 Composição farmacêutica compreendendo lactobacillus plantarum e arginina BR9608284A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Publications (1)

Publication Number Publication Date
BR9608284A true BR9608284A (pt) 1999-06-08

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608284A BR9608284A (pt) 1995-05-09 1996-05-08 Composição farmacêutica compreendendo lactobacillus plantarum e arginina

Country Status (16)

Country Link
EP (1) EP0825869B1 (pt)
JP (1) JP4058560B2 (pt)
KR (1) KR19990008403A (pt)
CN (1) CN1152678C (pt)
AT (1) ATE221783T1 (pt)
AU (1) AU704886B2 (pt)
BR (1) BR9608284A (pt)
CA (1) CA2220498A1 (pt)
DE (2) DE825869T1 (pt)
EE (1) EE03597B1 (pt)
ES (1) ES2112818T3 (pt)
GR (1) GR980300028T1 (pt)
NO (1) NO317668B1 (pt)
PL (1) PL184603B1 (pt)
SE (1) SE9501719D0 (pt)
WO (1) WO1996035440A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
AU783439C (en) 2000-03-24 2006-12-14 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005094848A1 (ja) * 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
EP3067057B1 (en) 2005-09-28 2022-11-09 Nordic Rebalance A/S Probiotic fermented cereal compositions for use in treatment of gastrointestinal disorders caused by pro-inflammatory bacteria
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
JP5823695B2 (ja) * 2008-12-03 2015-11-25 国立大学法人広島大学 肝機能障害予防剤
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌cmu995菌株之新用途
KR102665545B1 (ko) 2017-04-17 2024-05-13 더 유니버서티 오브 시카고 인간 건강에의 적용 및 질환의 치료를 위한 장으로의 단쇄 지방산의 전달을 위한 중합체 재료
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
EP0825869B1 (en) 2002-08-07
JPH11504936A (ja) 1999-05-11
EP0825869A1 (en) 1998-03-04
DE69622855D1 (de) 2002-09-12
ATE221783T1 (de) 2002-08-15
SE9501719D0 (sv) 1995-05-09
GR980300028T1 (en) 1998-04-30
KR19990008403A (ko) 1999-01-25
NO975136D0 (no) 1997-11-07
JP4058560B2 (ja) 2008-03-12
NO975136L (no) 1997-11-07
DE69622855T2 (de) 2003-04-10
PL323320A1 (en) 1998-03-16
AU5784696A (en) 1996-11-29
NO317668B1 (no) 2004-11-29
PL184603B1 (pl) 2002-11-29
EE9700269A (et) 1998-04-15
EE03597B1 (et) 2002-02-15
CA2220498A1 (en) 1996-11-14
WO1996035440A1 (en) 1996-11-14
CN1190346A (zh) 1998-08-12
ES2112818T1 (es) 1998-04-16
CN1152678C (zh) 2004-06-09
ES2112818T3 (es) 2003-02-16
DE825869T1 (de) 1998-07-16
AU704886B2 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
BR9608284A (pt) Composição farmacêutica compreendendo lactobacillus plantarum e arginina
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
DE69831578D1 (de) Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
TR200102058T2 (tr) Lactobacillus salivarius'un kullanımı
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
WO2002083879A3 (en) Immunotherapy based on dendritic cells
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
JPS6483025A (en) Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
Samuel Paediatrics Forum. Acute diarrhoea
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
AU1756299A (en) Use of putamen ovi

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2014 DE 11/08/2009.